Introduction
Ovarian sex-cord stromal tumors represent 5% of ovarian neoplasm cases, it can occur at any age (mean age early fifties) and generally, they present as an adnexal mass, or a haemoperitoneum, with an estrogenic pattern linked to metrorrhagia, endometrial hyperplasia or adenocarcinoma.
These tumors show a differentiation in sex cordons or in specialized stroma: the latter includes female cellular type (granulosa or theca cell), male cellular type (Sertoli or Leydig cells) and undifferentiated elements.
Cellular variety of sex-cord stromal tumor shows various degrees of differentiation, reproducing a proliferating pattern present in embryogenesis [1] .
Pathological Findings of Ovarian Sex-Cord Stromal Tumors (SCST)
Granulosa cell tumors contain two histotypes: the young type and the adult type; the latter arises frequently after menopause, but it can also occur in puberty, associated with hyperestrogenism in 75% of total cases, leading to precocious puberty in children and metrorrhagia in adults. Some of these cases are inactive in hormonal pattern and some are caused by androgen producers [2] .
Macroscopically, sex-cord stromal ovarian tumors are capsulated, vary in size and may be solid or partially cystic; the cut surface may be grey-white or yellow, depending on lipid contents; moreover, necrosis and haemorrhage are often present inside the capsule, with cystic compartments filled with fluid or clotted blood.
The microscopic features of sex-cord stromal ovarian tumors may be extremely changeable, even in the same tumor, with a wide variety of patterns and characteristic Call-Exner bodies may be present; they can have in some cases a microfollicular or macrofollicular growth, and in other cases trabecular or insular.
In microscopic diagnosis, cellular elements are often in the shape of coffee beans and, at an immunohysto-chemical level sex-cord stromal ovarian tumors express: estradiol or vimentin, inhibin, CD 99 and cytocheratin, with a reactivity to S100 marker in 50% of cases [3, 4] .
Currently, the gold standard treatment for SCST is by surgery, even if its surgical management for early-stage adult patients is not well defined. inserted through an intra umbilical vertical incision. Following the application of carbon dioxide pneumoperitoneum, with intra-abdominal pressure maintained at 15 mmHg, the abdominal cavity was inspected through a zero-degree laparoscope (Karl Storz, Tuttlingen, Germany), connected to a video monitor; three supra-pubic ancillary trocars were placed as follows: one 10 mm of diameter trocar inserted in the midline, 3 cm under the umbilicus, and one in each iliac fossa (5 mm of diameter on the left side and 5 mm of diameter on the right size), laterally to inferior epigastric vessels. Before both operative procedures, all pelvic structures were inspected and the abdomen was explored through the laparoscope clockwise. The pelvic-abdominal inspection showed a right ovarian cyst, with a regular surface (Figure 1 ), some filmy adhesions in the pouch of Douglas and between the posterior uterine wall and right ovary and tube. The uterus had multiple fibroids and the left ovary was normal; following the patient's decision to receive mini- mally invasive treatment (previously signed on informed consent), right ovariectomy was performed by surgeons using a spill-proof endoscopic device (Endobag, Ethicon Endo-Surgery, Johnson & Johnson Company, USA). In detail, lysis of right ovarian cysts adhesions was performed by aqua dissection with an irrigating probe and, after this, adnexectomy was carried out with a bipolar forceps that coagulated the meso-ovarian vessels, the uterus-ovarian and infundibolopelvic ligaments, while the ovary was sustained by two Manhes forceps. The coagulated ligaments were cut with a monopolar endoscissor and lastly, the tubal wound was irrigated and the haemostasis was re-obtained with fine bipolar scissors. The excised cyst, emptied in Endobag through a laparoscopic sucking-up pin, was removed via one of the trocar through a spill-proof endoscopic device, to avoid accidental leakage of the ovarian cyst content into the peritoneal cavity, which can worsen the prognosis if the cyst turns out to be malignant or can lead to peritonitis if the cyst is a dermoid or mucinous cyst. Following laparoscopy, Dilatation & Courretage was performed, due to her history of bleeding. The surgical procedure lasted 20 minutes and intra-laparoscopic blood loss was less than 80 cc.
Short Report of an
The frozen section histology suggested an ovarian SCST, possibly a granulosa cell tumor, while macroscopic examinations showed a smooth right ovarian cortical surface. Following pathologists' advice, in agreement with the patient's preliminary decision and based on her advanced postmenopausal status and slow tumor growth, the surgeons performed a total laparoscopic hysterectomy (TLH) with left salpingo-ophorectomy (SO), which avoided radical treatment by surgical staging, lymphadenectomy, appendectomy and omentectomy.
Preliminarily, the authors inserted in uterus a transvaginal uterine manipulator (Endopath, Ethicon Endosurgery, Inc., Cincinnati, USA) to quickly mobilize the uterus during the procedure and activated PK System LYONS Dissecting Forceps and PK System LP Scissors (Gyrus Medical, Inc. Maple Grove, MN, USA). The left broad ligament anterior leaf was opened while the nurse pushed the uterus into retro-version; the left broad ligament posterior leaf was opened to allow the utero-ovarian ligament and tubes to be defined. This step was performed with PK System LYONS dissecting coagulating forceps and PK System LP monopolar scissors, followed by dissection of the same broad ligament. The uterus was pushed by the nurse towards the opposite side, to the right, using uterine manipulator traction; the left uterine vessels were isolated, the left utero-vesical pouch peritoneum was opened by dissecting and grasping coagulating forceps and the bladder was delicately pushed downwards. The surgeons completed the uterine devascularization procedure, after dissecting the left broad ligament: they closed the uterine pedicle with a 0 Vicryl, using a knot pusher after inserting a needle round the uterine vessels. The left uterine vessels were ligated in two places and incised with scissors between the knots, with final haemostasis of the uterine vessels through bipolar forceps, after checking first the position of the ureters. The same actions were performed on the right side of uterus, where the ophorectomy had been previously done. Intra-fascial hysterectomy was continued using the same dissecting coagulating forceps and monopolar scissors, coagulating the cervicovaginal vessels and opening the vagina; anterior and posterior vaginal walls were incised with monopolar scissors and haemostasis was completed through coagulating forceps. After uterine extraction, surgeons performed laparoscopic suturing of the vaginal cuff. The hysterectomy took 65 minutes and the intralaparoscopic blood loss was 200 cc. The final examination highlighted: a granulosa cell tumor of right ovary ( Figure 2) ; the uterus showed fibroids and a cystic glandular hyperplasia of endometrium, the left ovary was atrophic.
The FIGO Staging of SCST was IA. The histochemical analysis showed positive reaction to estrogen receptors, with a proliferating index (KI-67-clone MIB1) of 8% in neoplastic cells. Postoperative recovery was normal, the patient was regularly discharged 3 days after laparoscopy, with no additional therapy at remission and has been followed up for the past three years with instrumental and biochemical monitoring.
Discussion
In this patient, the surgeons performed a minimally invasive treatment of SCST, avoiding radical treatment by surgical staging with pelvic and para-aortic lymphadenectomy, appendectomy and omentectomy, for the following reasons:
The woman had agreed on minimally invasive treatment, since presurgical assessment did not show ad- vanced malignancy suspect of ovarian cancer; after the frozen section results, surgeons decided the total laparoscopical non-radical unstaged approach either for the patient's advanced postmenopausal age, or for the biology of granulosa ovarian mass-a tumor at slow growing.
The morbidity and morbility of a radical laparoscopic approach, with pelvic and para-aortic lymphadenectomy, appendectomy and omentectomy, collide with the patient wish and with the stage and the biology of the tumor, since more than 95% of SCST are in first stage, with a mitotic index less than 3 mitosis for 10 HPF in 75% of cases [5] .
A recent study by Brown et al. affirm that lymph node metastasis in ovarian SCST are rare [6] .
The stage of disease is the most important prognostic factor associated with the risk of relapse: the 5-year survival rate of stage I ovarian SCST is 86-96% and all other stages are between 26-46% [7] .
There have been only a few case reports on distant metastases from these tumors [8, 9] .
Nevertheless, adult types have a better prognosis than young types, and trabecular and follicular histological pattern has a better prognosis than sarcomatoid pattern. Generally, bilateral involvement of the ovaries in SCST is observed in only 2% of cases, the opposite ovary can be preserved in younger women, while, if the uterus needs to be preserved, endometrium biopsy should be performed because the synchronous occurrence of endometrial adenocarcinoma is associated with estrogen secretion [10] .
The differential histological diagnosis of ovarian SCST is with: undifferentiated carcinoma, small cell carcinoma, endometrial stroma sarcoma, cellular fibroid, endometrioid carcinoma with a sex cord-like growing pattern, gonadoblastoma, melanoma or malignant mam-malian lobular tumor metastasis [2, 3] .
The SCST prognosis depends on clinical stage, dimension, cellular atipia presence and tumor rupture [11] .
As for recurrence, ovarian SCST can recur long after initial treatment and locally, with an average interval of 5-10 years, with rare metastasis at distance; the longest reported interval is 37 years, therefore lifelong follow-up care is needed [12] .
Factors reported to be associated with outcome include: presentation stage, age older than 40, tumor size, tumor rupture, histologic pattern, high mitotic count, and nuclear atypicality.
The SCST recurrences are peritoneal and retro-peritoneal masses, histologically well expressed [13] .
Patients with recurrent disease or residual disease after surgery should be treated with a combination of bleomycin, etoposide, and cisplatin (BEP), while no evidence shows that treatment with progesterone is beneficial and the role of the radiation therapy, especially for palliation in recurrent disease in the pelvis, has yet to be proven [10, 12] .
A recent article examined the clinical efficacy of bevacizumab with or without concurrent chemotherapy and evaluated the angiogenic characteristics of these tumors; authors concluded that anti-VEGF therapy is highly effective in patients with granulosa cell tumors [13] .
For the prolonged surveillance, the tumor marker follow-up of ovarian SCST is through inhibin, a glycoprotein produced by granulosa cells, which may be increased in postmenopausal women with mucinous carcinomas [14] .
Concludingly, this short report differs from traditional treatments since the authors propose, for the first time, a minimally invasive treatment in a SCST, for the above reasons.
Primarily, the presurgical assessment did not show advanced malignancy suspect of ovarian cancer and the frozen section results confirmed it. Then, the biology of granulosa ovarian mass, a tumor at slow growing, confirms that lymph node metastasis of SCSTs are rare, so as the early stage of this tumor is the most important prognostic factor associated with the relapse risk, with a survival rate of 86-96% in stage I(5-year). Nevertheless, adult types have a better prognosis than young types. Finally, the mentioned patient was an elder postmenopausal women of 69 years, so the morbidity and morbility of a more radical laparoscopic approach collided with the patient wish and with the stage and the biology of the tumor.
Given that the literature is lack of laparoscopical treatments of SCST in adult age patients, based on our report, a prospective multicentre trial could be proposed using non-radical laparoscopy in postmenopausal patients with ovarian SCST.
Conclusions
Generally, SCST has been treated radically in young women [15] ; since there are no clear conclusions regarding the role of postoperative chemotherapy or radiotherapy in stage I patients and in those with complete resected tumor [16] , TLH plus BSO not followed by lymphadenectomy, has also proven, in our report, to be a safe and effective alternative in postmenopausal patients, with fast recovery and minimal morbidity and morbility. In view of all these findings and due to the technical advances in endoscopic surgery, laparoscopic non-radical treatment of SCST could be considered a safer treatment in selected and consenting adult age patients, which agrees with a minimally invasive surgery and with a successive prolonged surveillance, also defined as "wait and see" approach, since this tumor grows slowly.
